-
Je něco špatně v tomto záznamu ?
Considerations on equity in management of end-stage kidney disease in low- and middle-income countries
W. Van Biesen, V. Jha, AK. Abu-Alfa, SP. Andreoli, G. Ashuntantang, B. Bernieh, E. Brown, Y. Chen, R. Coppo, C. Couchoud, B. Cullis, W. Douthat, FU. Eke, B. Hemmelgarn, FF. Hou, NW. Levin, VA. Luyckx, RL. Morton, MR. Moosa, FEM. Murtagh, M....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
Europe PubMed Central od 2016 do Před 1 rokem
Elsevier Open Access Journals od 2011-06-01 do 2020-03-31
Elsevier Open Archive Journals od 2011-06-01 do Před 4 lety
Odkazy
PubMed
32149010
DOI
10.1016/j.kisu.2019.11.004
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
Department of Nephrology General University Hospital Charles University Prague Czech Republic
Department of Pediatrics University of Port Harcourt Teaching Hospital Port Harcourt Nigeria
Division of Nephrology Queen's University Kingston Ontario Canada
Fondazione Ricerca Molinette Regina Margherita Hospital Turin Italy
French Renal Epidemiology and Information Network Registry Biomedicine Agency Paris France
Imperial College Healthcare National Health Service Trust London UK
Mount Sinai Icahn School of Medicine New York New York USA
Nephrology Department Ghent University Hospital Ghent Belgium
NephroPlus Dialysis Centres Hyderabad India
Otto Loewi Research Center Medical University of Graz Graz Austria
Renal Unit Greys Hospital Pietermaritzburg South Africa
SEHA Dialysis Services Abu Dhabi United Arab Emirates
Wolfson Palliative Care Research Centre Hull York Medical School University of Hull Hull UK
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005062
- 003
- CZ-PrNML
- 005
- 20200605091712.0
- 007
- ta
- 008
- 200511s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.kisu.2019.11.004 $2 doi
- 035 __
- $a (PubMed)32149010
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Van Biesen, Wim $u Nephrology Department, Ghent University Hospital, Ghent, Belgium.
- 245 10
- $a Considerations on equity in management of end-stage kidney disease in low- and middle-income countries / $c W. Van Biesen, V. Jha, AK. Abu-Alfa, SP. Andreoli, G. Ashuntantang, B. Bernieh, E. Brown, Y. Chen, R. Coppo, C. Couchoud, B. Cullis, W. Douthat, FU. Eke, B. Hemmelgarn, FF. Hou, NW. Levin, VA. Luyckx, RL. Morton, MR. Moosa, FEM. Murtagh, M. Richards, E. Rondeau, D. Schneditz, KD. Shah, V. Tesar, K. Yeates, G. Garcia Garcia,
- 520 9_
- $a Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Jha, Vivekanand $u George Institute for Global Health India, New Delhi, India. Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India.
- 700 1_
- $a Abu-Alfa, Ali K $u Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
- 700 1_
- $a Andreoli, Sharon P $u Department of Pediatrics, Pediatric Nephrology, Indiana University Medical Center, Indianapolis, Indiana, USA.
- 700 1_
- $a Ashuntantang, Gloria $u Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde, Yaounde I, Cameroon.
- 700 1_
- $a Bernieh, Bassam $u Home Hemodialysis for Home Dialysis, Al Ain, United Arab Emirates. The Heart Medical Center, Al Ain, United Arab Emirates.
- 700 1_
- $a Brown, Edwina $u Imperial College Healthcare National Health Service Trust, London, UK.
- 700 1_
- $a Chen, Yuqing $u Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China. Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
- 700 1_
- $a Coppo, Rosanna $u Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Couchoud, Cecile $u French Renal Epidemiology and Information Network (REIN) Registry, Biomedicine Agency, Paris, France.
- 700 1_
- $a Cullis, Brett $u Renal Unit, Greys Hospital, Pietermaritzburg, South Africa.
- 700 1_
- $a Douthat, Walter $u Hospital Privado-Universitario de Cordoba and Instituto Universitario de Ciencias Biomédicas, Cordoba, Argentina.
- 700 1_
- $a Eke, Felicia U $u Department of Pediatrics, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.
- 700 1_
- $a Hemmelgarn, Brenda $u Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 700 1_
- $a Hou, Fan Fan $u State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- 700 1_
- $a Levin, Nathan W $u Mount Sinai Icahn School of Medicine, New York, New York, USA.
- 700 1_
- $a Luyckx, Valerie A $u Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland. Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- 700 1_
- $a Morton, Rachael L $u National Health and Medical Research Council Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
- 700 1_
- $a Moosa, Mohammed Rafique $u Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
- 700 1_
- $a Murtagh, Fliss E M $u Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.
- 700 1_
- $a Richards, Marie $u SEHA Dialysis Services, Abu Dhabi, United Arab Emirates.
- 700 1_
- $a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France. Sorbonne Université, Paris, France.
- 700 1_
- $a Schneditz, Daniel $u Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
- 700 1_
- $a Shah, Kamal D $u NephroPlus Dialysis Centres, Hyderabad, India.
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Yeates, Karen $u Division of Nephrology, Queen's University, Kingston, Ontario, Canada.
- 700 1_
- $a Garcia Garcia, Guillermo $u Servicio de Nefrologia, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Hospital 278, Guadalajara, Jalisco, Mexico.
- 773 0_
- $w MED00203343 $t Kidney international supplement $x 2157-1724 $g Roč. 10, č. 1 (2020), s. e63-e71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32149010 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200605091710 $b ABA008
- 999 __
- $a ind $b bmc $g 1523992 $s 1095117
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 1 $d e63-e71 $e 20200219 $i 2157-1724 $m Kidney international supplement $n Kidney Int Suppl (2011) $x MED00203343
- LZP __
- $a Pubmed-20200511
